Q3 Results Impact: SBI Card, SBI Life Slip 3%, Gland Pharma Jumps 9% on Earnings Reaction
The Q3 results impact was clearly visible on Dalal Street as earnings numbers drove sharp, stock-specific moves on January 29. While SBI Card and SBI Life Insurance saw selling pressure after their December-quarter numbers failed to meet market sentiment, Gland Pharma stood out with a strong rall...
Easy & quick